GENNBIO
GENNBIO
Industry:
Biotechnology Medical Product Research
Founded:
1989-01-01
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.gennbio.co.kr
Status:
Active
Contact:
+82-31-6063120
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Font Awesome Apache Sitelinks Search Box ReCAPTCHA Person Schema Facebook Pixel
Similar Organizations
SEIKOTEC
SEIKOTEC develops software products for medical and research institutes.
More informations about "GenNBio"
GenNBio Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for GenNBio Inc. of Pyeongtaek, Gyeonggi. Get the latest business insights from Dun & Bradstreet.See details»
GenNBio
R&d, ๋ฐ์ด์ค ์ฐ์ , ์ ์ฝ ๋ฐ ๋ฐ์ด์ค ์ฅ๊ธฐ ๊ฐ๋ฐ, ์ฒจ๋จ ์๋ฃ๊ธฐ๊ธฐ ๊ฐ๋ฐ ํ๋ซํผ, ์ฅ๊ธฐ์ด์ ์ ๋ฌธ์ ์คํ ๋ฐ ๋ถ์See details»
Gennbio Company Profile 2024: Stock Performance
Gennbio has 45 total employees. What industry is Gennbio in? Gennbioโs primary industry is Biotechnology. Is Gennbio a private or public company? Gennbio is โฆSee details»
GenNBio - Crunchbase Company Profile & Funding
Organization. GenNBio . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... GenNBio is located in Seongnam, Kyonggi-do, South โฆSee details»
Company GenNBio Inc. - MarketScreener.com
Aug 2, 2018 GenNBio Inc, formerly KD Nature & Bio Co Ltd, is a company mainly engaged in the treatment of wastes. The Company is mainly involved in the provision of general and โฆSee details»
072520 | GenNBio Inc. Profile - MarketWatch
GenNBio Inc. GenNBio, Inc. engages in the manufacture of cell phone window components. It operates through the following business divisions: Window, Environment, Entertainment, and โฆSee details»
GenNBio Inc. Annual Report - fss.or.kr
[email protected]: Disclosure Contact: PARK JUN YOUNG: MANAGER: 031-606-3120: 031-628-0899: [email protected]: Form Information. Consolidated Financial Statements. โฆSee details»
GenNBio Inc.: Governance, Directors and Executives & Committees ...
Dec 31, 2023 GenNBio Inc, formerly KD Nature & Bio Co Ltd, is a company mainly engaged in the treatment of wastes. The Company is mainly involved in the provision of general and โฆSee details»
GenNBio Inc - Company Profile and News - Bloomberg Markets
Company profile page for GenNBio Inc including stock price, company news, executives, board members, and contact informationSee details»
072520.KR | GenNBio Inc. Company Profile & Executives - WSJ
Company profile for GenNBio Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed 072520.KR description & address.See details»
072520.KQ - | Stock Price & Latest News | Reuters
Nov 10, 2024 GenNBio Inc, formerly KD Nature & Bio Co Ltd, is a company mainly engaged in the treatment of wastes. The Company is mainly involved in the provision of general and โฆSee details»
GenNBio Inc. Stock (A072520) - Quote Korea S.E.- MarketScreener
Mar 21, 2024 GenNBio Inc. (A072520.KRX): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock GenNBio Inc. | Korea S.E.: A072520 | Korea S.E.See details»
072520 | GenNBio Inc. Stock Overview (S. Korea: KRX) - Barron's
Complete GenNBio Inc. stock information by Barron's. View real-time 072520 stock price and news, along with industry-best analysis.See details»
Gennbio to raise 10 bln won via stock offering - Yonhap News โฆ
SEOUL, March 22 (Yonhap) -- Gennbio Inc.on Wednesday announced that it will sell stock to raise 10 billion won (US$7.6 million). The proceeds from the stock sale will be used mainly to โฆSee details»
S.Korea's Genexine begins human trial of coronavirus vaccine
Jun 19, 2020 The project is a collaboration between the International Vaccine Institute, drug manufacturer Binex Co Ltd and biotech firm GenNBio Inc as well as the state-run Korea โฆSee details»
Gennbio licenses in two immunosuppressants valued up to
Jan 13, 2020 Gennbio Co. Ltd. has signed an agreement with fellow Korean biotech Genexine Inc. to in-license two immunosuppressant drug candidates called GX-P1 (PD-L1 hyfc) and โฆSee details»
GenBio Inc. โ Expanding Possibilities.
GenBio, Inc. is a Biotechnology Company specializing in researching a rare natural extract with significant phyto-activity profiles. We identified this extract, and that after ten years of โฆSee details»
Genenbio - Crunchbase Investor Profile & Investments
Genenbio is a biotech company that engages in drug and bio-organ development.See details»
Generation Bio Announces Breakthrough in its Non-Viral Genetic โฆ
Oct 18, 2023 โ Immune-quiet DNA (iqDNA) is a novel variant of closed-ended DNA (ceDNA) that evades host innate immune detection in both mice and non-human primates (NHPs) with โฆSee details»
GenBio Company Profile 2024: Valuation, Funding & Investors
GenBio General Information Description. Manufacturer of biopharmaceutical products intended to improve the overall health of human beings. The company operates a manufacturing plant and โฆSee details»